PT - JOURNAL ARTICLE AU - Ozsahin, Ilker AU - Onyebuchi, Confidence AU - Sekeroglu, Boran TI - Differentiating COVID-19 from other types of pneumonia with convolutional neural networks AID - 10.1101/2020.05.26.20113761 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.26.20113761 4099 - http://medrxiv.org/content/early/2020/05/27/2020.05.26.20113761.short 4100 - http://medrxiv.org/content/early/2020/05/27/2020.05.26.20113761.full AB - INTRODUCTION A widely-used method for diagnosing COVID-19 is the nucleic acid test based on real-time reverse transcriptase-polymerase chain reaction (RT-PCR). However, the sensitivity of real time RT-PCR tests is low and it can take up to 8 hours to receive the test results. Radiologic methods can provide higher sensitivity. The aim of this study is to investigate the use of X-ray and convolutional neural networks for the diagnosis of COVID-19 and to differentiate it from viral and/or bacterial pneumonia, as 2-class (bacterial pneumonia vs COVID-19 and viral pneumonia vs COVID-19) and 3- class (bacterial pneumonia, COVID-19, and healthy group (BCH), and among viral pneumonia, COVID- 19, and healthy group (VCH)) experiments.METHODS 225 COVID-19, 1,583 healthy control, 2,780 bacterial pneumonia, and 1,493 viral pneumonia chest X-ray images were used. 2-class- and 3-class-experiments were performed with different convolutional neural network (ConvNet) architectures, with different variations of convolutional layers and fully-connected layers.RESULTS The results showed that bacterial pneumonia vs COVID-19 and viral pneumonia vs COVID- 19 reached a mean ROC AUC of 97.32% and 96.80%, respectively. In the 3-class-experiments, macro-average F1 scores of 95.79% and 94.59% were obtained in terms of detecting COVID-19 among BCH and VCH, respectively.CONCLUSIONS The ConvNet was able to distinguish the COVID-19 images among non-COVID-19 images, namely bacterial and viral pneumonia as well as normal X-ray images.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The project built for creating this dataset was approved by the University of Montreal's Ethics Committee #CERSES-20-058-D. Informed consent was obtained for all subjects, and the study was approved by the relevant institutional review board at each data acquisition site. All methods were performed in accordance with the relevant guidelines and regulations. All chest X-ray imaging was performed as part of patients' routine clinical care. Institutional Review Board (IRB)/Ethics Committee approvals were obtained. The work was conducted in a manner compliant with the United States Health Insurance Portability and Accountability Act (HIPAA) and was adherent to the tenets of the Declaration of Helsinki.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in this study is available in the main text. https://github.com/ieee8023/covid-chestxray-dataset https://doi.org/10.17632/rscbjbr9sj.3